WTAP promotes the progression of ulcerative colitis by silencing the expression of CES2 through m6A modification
Journal of Autoimmunity · 2024
DOI: 10.1016/j.jaut.2024.103295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Autoimmunity, 2024. Verfasst von Xiaoran Xie und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China; Laboratory of Translational Gastroenterology, Qilu Hosp…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Disease Progression, Macrophages. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: This study will explore the function of WTAP, the critical segment of m6A methyltransferase complex, in UC and its regulation on immune response. METHODS: The expression levels of key proteins were detected in colon tissues which were derived from UC patients and mice. Macrophage polarization and CD4+ T cell infiltration were detected by flow cytometry and IF staining. ELISA assay was utilized to analyze the level of the inflammatory cytokines. m6A-RIP-PCR, actinomycin D test, and RIP assays were utilized to detect the m6A level, stability, and bound proteins of CES2 mRNA. A dual luciferase reporter assay was conducted to confirm the transcriptional interactions between genes. A co-culture system of intestinal epithelium-like organs was constructed to detect the primary mouse intestinal epithelial cells (PMIEC) differentiation. The interaction between proteins was detected via Co-IP assay. RESULTS: The expression of WTAP and CES2 in UC tissues was increased and decreased, respectively. Knockdown of WTAP inhibited the progression of UC in mice by inhibiting M1 macrophage polarization and CD4+ T cell infiltration. WTAP combined YTHDF2 to promote the m6A modification of CES2 mRNA and inhibited its expression. CES2 co-expressed with EPHX2 and overexpression of CES2 promoted the differentiation of PMIEC. The inhibitory effect of WTAP knockdown on the progress of UC was partially abrogated by CES2 knockdown. CONCLUSION: WTAP/YTHDF2 silences CES2 by promoting its m6A modification and then promotes the progression of UC. WTAP could be a promoting therapy target of UC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China; Laboratory of Translational Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China; Robot Engineering…
- Department of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Department of Gastroenterology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, China. Electronic address: zndxchenxiong@sina.com.
Zitieren
APA
Xie, X., Cheng, S., Chen, X., & Wang, X. (2024). WTAP promotes the progression of ulcerative colitis by silencing the expression of CES2 through m6A modification. Journal of Autoimmunity. https://doi.org/10.1016/j.jaut.2024.103295
Vancouver
Xie X, Cheng S, Chen X, Wang X. WTAP promotes the progression of ulcerative colitis by silencing the expression of CES2 through m6A modification. Journal of Autoimmunity. 2024. doi:10.1016/j.jaut.2024.103295
BibTeX
@article{Xie2024,
author = {Xie, Xiaoran and Cheng, Sha and Chen, Xiong and Wang, Xia},
title = {WTAP promotes the progression of ulcerative colitis by silencing the expression of CES2 through m6A modification},
journal = {Journal of Autoimmunity},
year = {2024},
doi = {10.1016/j.jaut.2024.103295}
}
EUVIMED